v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   96,722,098    
Beginning balance at Dec. 31, 2023 $ 324,941 $ 97 $ 760,210 $ (435,366)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 13,906   13,906  
Issuance of common stock upon restricted stock unit vesting (in shares)   483,517    
Issuance of common stock upon restricted stock unit vesting 0 $ 1 (1)  
Exercised stock options (in shares)   309,868    
Exercised stock options 1,171   1,171  
Payments for taxes related to net settlement of equity awards (5,678)   (5,678)  
Net loss (11,433)     (11,433)
Ending balance (in shares) at Mar. 31, 2024   97,515,483    
Ending balance at Mar. 31, 2024 322,907 $ 98 769,608 (446,799)
Beginning balance (in shares) at Dec. 31, 2024   102,088,783    
Beginning balance at Dec. 31, 2024 357,030 $ 102 833,129 (476,201)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 16,365   16,365  
Issuance of common stock upon restricted stock unit vesting (in shares)   697,506    
Issuance of common stock upon restricted stock unit vesting 0 $ 1 (1)  
Exercised stock options (in shares)   233,687    
Exercised stock options 1,523   1,523  
Capped call transaction (33,879)   (33,879)  
Stock-based compensation replacement awards related to merger consideration and attributable to pre-combination services 821   821  
Net loss (7,816)     (7,816)
Ending balance (in shares) at Mar. 31, 2025   103,019,976    
Ending balance at Mar. 31, 2025 $ 334,044 $ 103 $ 817,958 $ (484,017)